Inactive Instrument
Auspex Pharmaceuticals Inc Stock
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-04-22 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 15-04-22 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 2009-08-31 |
Rod Ferguson
BRD | Director/Board Member | 69 | 2012-12-31 |
Alex Zisson
BRD | Director/Board Member | 56 | 2013-10-16 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.98% | +5.73% | +54.45% | +113.83% | 70.88B | |
| -0.39% | +0.02% | +38.84% | +83.28% | 62.49B | |
| +5.26% | +7.86% | +40.29% | +30.06% | 26.34B | |
| +0.83% | -3.43% | -16.41% | +359.38% | 26.21B | |
| +2.02% | -0.87% | +1.85% | -7.92% | 24.13B | |
| 0.00% | +6.81% | +25.03% | -11.44% | 20.72B | |
| -2.54% | -3.36% | +149.64% | +324.48% | 15.69B | |
| -1.95% | +1.80% | +42.69% | +165.15% | 14.46B | |
| -5.32% | -8.25% | -10.53% | +823.50% | 14.24B | |
| Average | +0.32% | +0.81% | +36.20% | +208.92% | 30.57B | |
| Weighted average by Cap. | +1.43% | +2.17% | +37.42% | +153.59% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
